1.Hand, PJ, Haisma JA, Kwan J, et al. Interobserver agreement for the bedside clinical assessment of suspected stroke. Stroke 2006;37(3):776–80.CrossRefGoogle ScholarPubMed

2.Shinar, D, Gross, CR, Mohr, JP, et al. Interobserver variability in the assessment of neurologic history and examination in the Stroke Data Bank. Arch Neurol 1985;42(6):557–65.CrossRefGoogle ScholarPubMed

3.Manschot, S, van Passel, L, Buskens, E, Algra, A, van Gijn, J. Mayo and NINDS scales for assessment of tendon reflexes: between observer agreement and implications for communication. J Neurol Neurosurg Psychiatry 1998;64(2):253–5.CrossRefGoogle ScholarPubMed

4.Sackett, DL, Haynes, RB, Tugwell, P (eds.). Clinical Epidemiology. A Basic Science for Clinical Medicine. Boston/Toronto: Little Brown and Company; 1985.Google Scholar

5.Brozek, JL, Akl, EA, Jaeschke, R, et al. GRADE Working Group, Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy 2009;64(8):1109–16.Google Scholar

6.Post, PN, Kievit J, van Baalen JM, van den Hout WB, van Bockel J. Routine duplex surveillance does not improve the outcome after carotid endarterectomy: a decision and cost utility analysis. Stroke 2002;33(3):749–55.CrossRefGoogle Scholar

7.Donnan, GA, O'Malley, HM, Quang, L, Hurley, S, Bladin, PF. The capsular warning syndrome: pathogenesis and clinical features. Neurology 1993;43(5):957–62.CrossRefGoogle ScholarPubMed

8.Saposnik, G. Noel de Tilly, L, Caplan, LR. Pontine warning syndrome. Arch Neurol 2008;65(10):1375–7.CrossRefGoogle ScholarPubMed

9.Paul, NL, Simoni, M, Chandratheva, A, Rothwell, PM. Population-based study of capsular warning syndrome and prognosis after early recurrent TIA. Neurology 2012;79(13):1356–62.CrossRefGoogle ScholarPubMed

10.Lee, H, Cho, YW. A case of isolated nodulus infarction presenting as a vestibular neuritis. J Neurol Sci 2004;221(1–2):117–19.CrossRefGoogle ScholarPubMed

11.Fonseca, AC, Canhão, P. Diagnostic difficulties in the classification of transient neurological attacks. Eur J Neurol 2011;18(4):644–8.CrossRefGoogle ScholarPubMed

12.Shenoy, AM. Guidelines in practice: therapies for benign paroxysmal positional vertigo. Continuum (Minneap Minn) 2012;18(5 Neuro-otology):1172–6.Google ScholarPubMed

13.Fazekas, F, Schmidt, R, Kleinert, R, Kapeller, P, Roob, G, Flooh, E. The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates. J Neural Transm Suppl 1998;53:31–9.CrossRefGoogle ScholarPubMed

14.Schmidt, R, Enzinger, C, Ropele, S, Schmidt, H, Fazekas, F; Austrian Stroke Prevention Study. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 2003;361(9374):2046–8.CrossRefGoogle ScholarPubMed

15.Gouw, AA, van der Flier, WM, Fazekas, F, et al. LADIS Study Group. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke 2008;39(5):1414–20.CrossRefGoogle Scholar

16.Fazekas, F, Schmidt, R, Scheltens, P. Pathophysiologic mechanisms in the development of age-related white matter changes of the brain. Dement Geriatr Cogn Disord 1998;9(suppl 1):2–5.CrossRefGoogle ScholarPubMed

17.Gouw, AA, Seewann, A, van der Flier, WM, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011;82(2):126–35.CrossRefGoogle ScholarPubMed

18.Potter, GM, Doubal, FN, Jackson, CA, Sudlow, CL, Dennis, MS, Wardlaw, JM. Lack of association of white matter lesions with ipsilateral carotid artery stenosis. Cerebrovasc Dis 2012;33 (4):378–84.CrossRefGoogle ScholarPubMed

19.Agarwal, R, Sze, G. Neuro-Lyme disease: MR imaging findings. Radiology 2009;253(1):167–73.CrossRefGoogle ScholarPubMed

20.Harboe, E, Beyer, MK, Greve, OJ, et al. Cerebral white matter hyperintensities are not increased in patients with primary Sjögren’s syndrome. Eur J Neurol 2009;16(5):576–81.CrossRefGoogle Scholar

21.Sierra, C. Associations between ambulatory blood pressure parameters and cerebral white matter lesions. Int J Hypertens 2011;2011:478710.Google ScholarPubMed

22.Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33(9):629–808.CrossRefGoogle Scholar

23.Fisher, CM. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci 1980;7(1):9–17.Google ScholarPubMed

24.Fisher, CM. Late-life migraine accompaniments – further experience. Stroke 1986;17(5):1033–42.CrossRefGoogle ScholarPubMed

25.Swartz, RH, Kern, RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 2004;61(9):1366–8.CrossRefGoogle ScholarPubMed

26.Hamedani, AG, Rose, KM, Peterlin, BL, et al. Migraine and white matter hyperintensities: the ARIC MRI study. Neurology 2013;81(15):1308–13.CrossRefGoogle ScholarPubMed

27.Kernan, WN, et al. on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. A guideline for Healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014.;45(7):2160–236.CrossRefGoogle ScholarPubMed

28.Arachchillage, DR, Machin, SJ, Cohen, H. Antithrombotic treatment for stroke associated with antiphospholipid antibodies. Expert Rev Hematol 2014;7(2):169–72.Google ScholarPubMed

29.European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25(5):457–507.CrossRefGoogle Scholar

30.Kokkinis, C, Vlychou, M, Zavras, GM, Hadjigeorgiou, GM, Papadimitriou, A, Fezoulidis, IV. The role of 3D-computed tomography angiography (3D-CTA) in investigation of spontaneous subarachnoid haemorrhage: comparison with digital subtraction angiography (DSA) and surgical findings. Br J Neurosurg 2008;22(1):71–8.CrossRefGoogle ScholarPubMed

31.Lu, L, Zhang, LJ, Poon, CS, et al. Digital subtraction CT angiography for detection of intracranial aneurysms: comparison with three-dimensional digital subtraction angiography. Radiology 2012;262(2):605–12.CrossRefGoogle ScholarPubMed

32.Hart, RG, Pearce, LA, Aguilar, MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146(12):857–67.CrossRefGoogle ScholarPubMed

33.Camm, AJ, et al. ESC Committee for Practice Guidelines-CPG; Document Reviewers. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation – developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14(10):1385–413.Google ScholarPubMed

34.Lip, GY. Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary. J Thromb Haemost 2013;11(4):615–26.CrossRefGoogle ScholarPubMed

35.Pisters, R, Lane, DA, Nieuwlaat, R, de Vos, CB, Crijns, HJ, Lip, GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138(5):1093–100.CrossRefGoogle ScholarPubMed

36.Koennecke, HC. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 2006;66(2):165–71.CrossRefGoogle ScholarPubMed

37.Cordonnier, C, Al-Shahi Salman, R, Wardlaw, J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 2007;130(Pt 8):1988–2003.CrossRefGoogle ScholarPubMed

38.Lovelock, CE, Cordonnier, C, Naka, H, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke 2010;41(6):1222–8.CrossRefGoogle ScholarPubMed

39.Cordonnier, C. Brain microbleeds: more evidence, but still a clinical dilemma. Curr Opin Neurol 2011;24(1):69–74.CrossRefGoogle Scholar

40.Romero, JR, Preis, SR, Beiser, A, et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke 2014;45(5):1492–4.CrossRefGoogle ScholarPubMed

41.Gorter, JW. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 1999;53(6):1319–27.CrossRefGoogle ScholarPubMed

42.Charidimou, A, Shakeshaft, C, Werring, DJ. Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk. Front Neurol 2012;3:133. eCollection 2012.CrossRefGoogle ScholarPubMed

43.Man-Son-Hing, M, Laupacis, A. Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians’ fears often unfounded. Arch Intern Med 2003;163(13):1580–6.CrossRefGoogle ScholarPubMed

44.Devereaux, PJ, Anderson, DR, Gardner, MJ, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ 2001;323(7323):1218–22.CrossRefGoogle ScholarPubMed

45.van Beijnum, J, Lovelock, CE, Cordonnier, C, et al. SIVMS Steering Committee and the Oxford Vascular Study. Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain 2009;132(Pt 2):537–43.Google ScholarPubMed

46.Mohr, JP, Parides, MK, Stapf, C, et al. International ARUBA investigators. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014;383(9917):614–21.CrossRefGoogle ScholarPubMed

47.van Beijnum, J, van der Worp, HB, Buis, DR, et al. Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA 2011;306(18):2011–19.CrossRefGoogle ScholarPubMed

48.Spetzler, RF, Martin, NA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65(4):476–83.CrossRefGoogle ScholarPubMed

49.Spetzler, RF, Ponce, FA. A 3-tier classification of cerebral arteriovenous malformations. Clinical article. J Neurosurg 2011;114(3):842–9.CrossRefGoogle ScholarPubMed

50.Molina, CA, Selim, MH. Unruptured brain arteriovenous malformations. Keep calm or dance in a minefield. Stroke 2014;45(5):1543–4.CrossRefGoogle ScholarPubMed